BioNTech SE: CEO Sahin Ugur sold 34,000 shares

What happened Sahin Ugur, CEO, sold 17,000 shares at $97.46 on Oct 1, 2026 for $1,656,745 and 17,000 shares at $96.72 on Oct 2, 2026 for $1,644,323, totaling 34,000 shares and $3,301,068.

Key details

• Transaction dates and prices: Oct 1, 2026 — 17,000 shares at $97.46 (code S); Oct 2, 2026 — 17,000 shares at $96.72 (code S).
• Filing date and report period: Form filed Oct 2, 2026; period of report Oct 1, 2026.
• Shares owned after the transaction: not disclosed in the information provided in this summary.
• Footnote (F1): the ordinary shares are held by Medine GmbH; the reporting person is the sole shareholder of Medine GmbH; 106,721 ordinary shares noted are held for the benefit of an individual under a trust, with Medine GmbH exercising voting but not dispositive power; the reporting person may be deemed to beneficially own the shares held by Medine GmbH.
• Remark: the sales were effected pursuant to a Rule 10b5-1 trading plan established on June 3, 2026.

Why it may matter

• The transactions reported are open-market sales executed under a prearranged Rule 10b5-1 plan.
• The filing discloses indirect holdings through Medine GmbH and notes potential beneficial ownership treatment under F1.
• A filing does not show why the insider traded or why the company acted.